The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 18, 2020
Filed:
May. 06, 2019
Applicant:
Xspray Microparticles Ab, Solna, SE;
Inventors:
Magnus Brisander, Ekerö, SE;
Mustafa Demirbüker, Järfälla, SE;
Gérald Jesson, Knivsta, SE;
Martin Malmsten, Höllviken, SE;
Helene Dérand, Höllviken, SE;
Assignee:
XSPRAY MICROPARTICLES AB, Solna, SE;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/14 (2006.01); A61K 9/48 (2006.01); A61K 38/00 (2006.01); A61K 31/497 (2006.01); A61K 31/505 (2006.01); B01F 3/00 (2006.01); A61K 31/44 (2006.01); A61K 31/517 (2006.01); A61K 9/51 (2006.01); A61K 31/437 (2006.01); A61K 31/506 (2006.01); A61K 31/4439 (2006.01); A61K 31/4545 (2006.01); A61K 31/5377 (2006.01); A61K 47/32 (2006.01); A61K 47/38 (2006.01); A61K 31/444 (2006.01); A61K 9/16 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/44 (2013.01); A61K 9/0053 (2013.01); A61K 9/14 (2013.01); A61K 9/1641 (2013.01); A61K 9/1652 (2013.01); A61K 9/5138 (2013.01); A61K 9/5146 (2013.01); A61K 9/5161 (2013.01); A61K 9/5192 (2013.01); A61K 31/437 (2013.01); A61K 31/444 (2013.01); A61K 31/4439 (2013.01); A61K 31/4545 (2013.01); A61K 31/506 (2013.01); A61K 31/517 (2013.01); A61K 31/5377 (2013.01); A61K 47/32 (2013.01); A61K 47/38 (2013.01);
Abstract
The present invention relates to the field of methods for providing pharmaceutical compositions comprising poorly water-soluble drugs. In particular the present invention relates to compositions comprising stable, amorphous hybrid nanoparticles, comprising at least one protein kinase inhibitor and at least one polymeric stabilizing and matrix-forming component, useful in pharmaceutical compositions and in therapy.